AKT1 and breast cancer: In addition, silencing of lncRNA HOTAIR significantly decreased the phosphorylation of PI3K, AKT, and mTOR and attenuated the resistance of BC cells to doxorubicin by inhibiting the PI3K/AKT/mTOR pathway [62].